This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Original Research

A Review of the Diagnosis, Pharmacologic Treatment, and Economic Aspects of Anxiety Disorders

Steven R. Arikian, MD, and Jack M. Gorman, MD

Published: June 1, 2001

Article Abstract

As many as 1 in 4 Americans will experience an anxiety disorder at some point in their lives, and many will also suffer the depression, substance abuse, distressing physical signs, and socioeconomic problems that often accompany these disorders when left untreated. Anxiety disorders can be detected using simple screening tools in the physician’s office. Early and effective treatment with appropriate medication can significantly reduce the psychic and physical symptoms of anxiety, lowering the overall costs of the disorder to the health care system and society. Many drugs offer safe and effective relief of anxiety symptoms with few side effects or drug-drug interactions, and some offer symptomatic relief within 1 to 2 weeks.

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 3

Quick Links: